ATH 25.0% 0.5¢ alterity therapeutics limited

This tells us what we know but in black and white from the...

  1. 1,847 Posts.
    lightbulb Created with Sketch. 1
    This tells us what we know but in black and white from the company. In the SUVR greater than 2.5 group there was a statistically significant reduction in amyloid burden. In the less than 2.5 SUVR group there was not. It also showed a signal toward HA reduction (which we knew). IMO, we don't have all the data for other measures (ie. cognition etc), the placebo issues confounded the other measures and statistical measures between the treated and untreated groups.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $26.19M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $27.94K 6.050M

Buyers (Bids)

No. Vol. Price($)
46 57663299 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 56205001 43
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 20524121
Last updated 15.46pm 29/03/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.